Pinsent Masons LLP is a leading player in the patents space, with a growing team working with a similarly growing client base. The practice, which is commended for its ‘technical expertise and legal acumen’ as well as its gender diversity, has vast experience in sectors including energy, technology and telecoms. IP and life sciences head Clare Tunstall's practice exclusively focuses on life sciences - alongside her leadership of the team, she is also relationship partner for key patent litigation clients; a notable area of strength for the practice. Noted practitioners included Charlotte Weekes, who heads up the generics and biosimilars focus group, heavy-duty patent litigator Christopher Sharp, and Allistair Booth, who leads the life sciences transactional IP team. Mark Marfé is known for being ’technically adept in the software and telecoms space'.
Testimonials
Collated independently by Legal 500 research team.
- 'The IP team at Pinsent are an impressive bunch across the board both in terms of technical expertise and legal acumen. They are also industry-leading on the gender diversity front.'
- 'Mark Marfé is a high quality individual. He is highly responsive, which is always greatly appreciated, and technically very adept in the software and telecoms space.'
Key clients
- Flynn Pharma
- Teva Pharmaceutical Industries
Work highlights
- Advised Flynn Pharmaceuticals on proceedings against Mylan in relation to Circadin
- Representing Teva in proceedings in the Patents Court against Bristol-Myers Squibb and Pfizer in relation to the blockbuster anticoagulant drug Eliquis.